The initiative is part of a restructuring to preserve cash while the company completes the design of the robotic surgery ...

The takeover extends a string of deals that have consolidated the outreach lab services market.

The ruling removes a barrier to a deal the FTC claims will eliminate competition in the outsourced hydrophilic coatings ...

Organon tripled sales of the bleeding-control system from 2022 to 2024 and is on track to grow sales again this year.

The financing comes 11 months after Cornerstone raised $70 million to support the launch of its device in China.

The Senate overcame a key procedural hurdle on Sunday after eight Democrats broke with their party to back a measure freeing ...

The decision is a “natural next step in our journey to becoming a fully independent company,” Siemens Healthineers CEO Bernd ...

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

Medtronic reached a critical juncture last month in its quest to build the market for renal denervation, a new device-based ...

MMI won FDA approval to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass ...

The company also posted weaker third-quarter results, but CEO David Fischel said orders for the new GenesisX system, when ...

The House passed a stopgap funding bill and President Donald Trump signed it late Wednesday, reopening the government without ...